Symptom-onset dosing for PMDD: what it means

Symptom-onset dosing is a way of taking an SSRI only on the days you have premenstrual symptoms, instead of every day of the month. Researchers have studied three dosing patterns for PMDD:

• Daily dosing: the SSRI every day of the month
• Luteal-phase dosing: the SSRI for the two weeks before your period
• Symptom-onset dosing: the SSRI only once symptoms begin

In the trials, women started the SSRI the day symptoms began, continued through the first few days of their period, and stopped until the next cycle. A doctor would confirm this timing against two cycles of tracked symptoms before suggesting it, since starting or stopping an SSRI is a decision for a doctor, not a fixed schedule to follow on your own.

A doctor would want you to track your cycle first, so the timing matches your actual pattern rather than a guess.

Symptom-onset dosing is studied for PMDD, not everyday PMS. PMDD is a diagnosis in the DSM-5-TR and ICD-11: at least five symptoms, including a mood symptom such as irritability or low mood, in the final week before your period, easing within a few days of it starting. What causes PMDD explains why some people react to normal hormone shifts this way.

PMS covers a wider range of physical or emotional symptoms in the one to two weeks before a period, and usually eases with simpler steps like sleep, movement or over-the-counter pain relief. SSRIs, including symptom-onset dosing, aren't typically used for PMS alone. They're reserved for PMDD, where mood symptoms get in the way of work, relationships or daily life.

If you don't know whether your pattern fits PMS or PMDD, tracking symptoms daily across two cycles is how doctors tell them apart, not a single week before your period.

Trials have tested symptom-onset dosing against placebo, and in one small trial against luteal-phase dosing, using several SSRIs.

The sertraline trials are the largest and most consistent. Smaller trials of other SSRIs point the same direction but need more women to confirm it. For comparison, daily sertraline also improves PMDD symptoms (JAMA, 1997, n=243), so researchers test symptom-onset dosing as a shorter schedule for the same drug.

Symptom-onset dosing matters because it can mean fewer days on medication each month, which some women prefer once their pattern is predictable. It only works well if you have a good sense of when your symptoms usually start, which is where tracking comes in.

Two related ideas help explain why timing matters:

• Allopregnanolone, a hormone byproduct that affects mood and falls along with progesterone before your period
• Corpus luteum, the structure in your ovary that produces that progesterone and starts to break down in the days before bleeding

If you're considering this with a doctor, a few steps help:

1. Track your symptoms daily for at least two cycles, noting the day each one starts and ends
2. Bring those notes to a GP or gynecologist, who can confirm whether the pattern fits PMDD
3. Discuss whether symptom-onset, luteal-phase or daily dosing suits your pattern and preferences

Niyora is a PMS and PMDD support app. Its estimated PMS window can help you see roughly when symptoms tend to start each cycle, useful context to bring to a doctor. For how these hormone shifts work more broadly, see menstrual cycle hormones, phase by phase or the full PMDD overview.